Article
KRAS mutation increases histone H3 lysine 9 lactylation (H3K9la) to promote colorectal cancer progression by facilitating cholesterol transporter GRAMD1A expression.
Cell death and differentiation - 1 Dec 2025
Zhang Chi, Yu Runfeng, Li Senmao, Yuan Ming, Hu Tuo, Liu Jiaqi, Ke Haoxian, Ye Shubiao, Yun Jihye, Huang Junfeng, Liang Guanzhan, Chen Shaopeng, Wu Xianrui, Lan Ping
Abstract excerpt
Histone lactylation is a novel epigenetic modification derived from lactate, but its role and mechanism in KRAS mutant colorectal cancer (CRC) progression remains to be fully elucidated. In this study, we first showed that mutant KRAS increased H3 lysine 9 lactylation (H3K9la) to promote CRC progression. We found that KRAS-mutant CRC tissues and cell lines exhibited higher lactylation and H3K9la levels compared...
Read the complete abstract on PubMedTopics
- Colorectal Neoplasms
- Humans
- Histones
- Proto-Oncogene Proteins p21(ras)
- Animals
